Viewing Study NCT04630158

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-01-24 @ 5:55 PM
Study NCT ID: NCT04630158
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2020-11-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Ocular Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eye pain View
None Dry eye like symptoms View
None Ocular surface pain View
None Corneal induced chronic pain View
None neuropathic eye pain View
None post-operative corneal induced chronic pain View
None CICP View
None corneal View
None corneal pain View